Multidisciplinary Approach to the Study of Pelvic Pain (MAPP)
Number of Subjects in Study Archive: 1039
Study Design: Observational
Conditions: Cystitis, Interstitial, Pelvic Pain, Prostatic Diseases, Prostatitis, Urogenital Diseases
Duration: December 2009 – June 2014
# Recruitment Centers: 9
Treatment: None, observational only
Available Genotype Data: No
Image Summary: No
Transplant Type: None
Does it have dialysis patients: No
Clinical Trials URL:
The Multidisciplinary Approach to the Study of Chronic Pelvic Pain (MAPP) Research Network was established to focus on a broader approach to the study of Interstitial Cystitis (IC)/Painful Bladder Syndrome (PBS) in men and women, and Chronic Prostatitis (CP)/Chronic Pelvic Pain Syndrome (CPPS) in men. Participants with some form or symptoms of IC or CP were asked to join the Trans-MAPP Epidemiology and Phenotyping (EP) Study. Participants with no Urologic Pelvic Pain Syndromes as well as participants with specific conditions (Fibromyalgia (FM), Irritable Bowel Syndrome (IBS), Chronic Fatigue Syndrome (CFS)) were recruited for the Trans-MAPP Control Study. These participants were a reference/control group for the Trans-MAPP Epidemiology & Phenotyping (EP) Study.
Currently, only data from the baseline visit are available for request.
The goal of this study was to better understand how pain is felt in people with IC or CP. Questions were asked and information was gathered about the health and life of the participants for research purposes. The study aimed to improve the treatment of IC and CP.
Primary outcome measures: extensive data on risk factors and outcomes measures including: General Measures of Sociodemographics, Health, and Quality of Life; UCPPS Symptoms Measures; Non-urological Symptom Measures; Trait-like Personal Factors
Individuals are eligible for the study if they report a response of at least 1 on the pain, pressure, or discomfort scale and provide informed consent. There are separate eligibility criteria for individuals with IC/PBS and CP/CPPS.
For males or females with IC/PBS, individuals are eligible if they report an unpleasant sensation of pain, pressure or discomfort, perceived to be related to the bladder and/or pelvic region, associated with lower urinary tract symptoms for the majority of the time during any 3 months in the previous 6 months or for the majority of the time during the most recent 3 months.
For males with CP/CPPS, individuals are eligible if they report pain or discomfort in any of the 8 domains of the Male Genitourinary Pain Index for the majority of the time during any 3 months in the previous 6 months.
Exclusion criteria are documented in the study protocol.
The study has been completed, but the outcomes have not yet been made available.